2-(2-cyclopropyl-4-propan-2-ylphenyl)-5-(trifluoromethyl)-1,2,4-triazol-3-amine;sulfuryl dichloride
C15H17Cl2F3N4O2S — CID 174714305
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(2-cyclopropyl-4-propan-2-ylphenyl)-5-(trifluoromethyl)-1,2,4-triazol-3-amine;sulfuryl dichloride
2-(2-cyclopropyl-4-propan-2-ylphenyl)-5-(trifluoromethyl)-1,2,4-triazol-3-amine;sulfuryl dichloride (PubChem CID 174714305) has the molecular formula C15H17Cl2F3N4O2S and a molecular weight of 445.29 g/mol. Its IUPAC name is 2-(2-cyclopropyl-4-propan-2-ylphenyl)-5-(trifluoromethyl)-1,2,4-triazol-3-amine;sulfuryl dichloride.
Molecular Properties
| Compound Name | 2-(2-cyclopropyl-4-propan-2-ylphenyl)-5-(trifluoromethyl)-1,2,4-triazol-3-amine;sulfuryl dichloride |
|---|---|
| PubChem CID | 174714305 |
| Molecular Formula | C15H17Cl2F3N4O2S |
| Molecular Weight | 445.29 g/mol |
| Exact Mass | 444.04 |
| IUPAC Name | 2-(2-cyclopropyl-4-propan-2-ylphenyl)-5-(trifluoromethyl)-1,2,4-triazol-3-amine;sulfuryl dichloride |
| SMILES | CC(C)c1ccc(-n2nc(C(F)(F)F)nc2N)c(C2CC2)c1.O=S(=O)(Cl)Cl |
| InChI | InChI=1S/C15H17F3N4.Cl2O2S/c1-8(2)10-5-6-12(11(7-10)9-3-4-9)22-14(19)20-13(21-22)15(16,17)18;1-5(2,3)4/h5-9H,3-4H2,1-2H3,(H2,19,20,21); |
| InChIKey | JDVZLFPOZKTPQT-UHFFFAOYSA-N |
| XLogP | 4.58 |
| TPSA | 90.87 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 445.29 |
| LogP ≤ 5 | 4.58 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 174714305 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.